Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0+
SponsorMurdoch Childrens Research Institute

About this trial

Many babies born very preterm (\<32 weeks of pregnancy) require support to breathe from a breathing machine (mechanical ventilator) via a breathing tube. Although this keeps babies alive, it can damage their lungs. To reduce this damage, doctors and nurses try to change babies to gentler breathing support that does not require a breathing tube. This is usually done using a method called nasal continuous positive airway pressure (nCPAP) that uses a nosepiece to deliver breaths. This process of removing the breathing tube is called "extubation". Many babies will need the breathing tube put back in after extubation (for various reasons) and this is independently associated with poorer outcomes.

This research study aims to compare two ways of performing extubation - both of which are already used regularly by doctors and nurses. The "standard extubation" approach involves taking a baby's breathing tube out first, then applying the nosepiece and starting nCPAP. The more recent approach, called "prePAP", involves applying the nosepiece and starting nCPAP before taking the breathing tube out. Previous research suggests that a prePAP approach may provide better support for babies during extubation. However, larger studies are required before this approach is more commonly used.

This study is investigating whether extubating the baby with prePAP is better than extubating the baby without prePAP.

The main question it aims to answer is: Does initiating nCPAP before extubation in very preterm babies reduce the fall in their oxygen levels post-extubation?

Eligibility criteria

Qualifiers

The infant is admitted to participating NICU

The infant is born between 22+0 to 29+6 weeks gestational age

The infant has been on a form of invasive mechanical ventilation for at least 4 hours

The infant is being electively extubated for the first time from invasive mechanical ventilation to nCPAP

Disqualifiers

The infant is born <22 weeks or >30 weeks gestational age

The infant has a major congenital anomaly involving the cardiac, respiratory or gastrointestinal systems, or a known genetic syndrome or diagnosis that might affect respiratory course and outcomes

The infant has severe pulmonary hypoplasia due to anhydramnios or oligohydramnios before 22 weeks in which the neonatal clinician anticipates that pulmonary hypoplasia related respiratory failure will be the major respiratory problem in early postnatal life

The infant is receiving invasive mechanical ventilation via nasotracheal intubation

Trial design

Treatments tested in this trial

  • Pre-extubation continuous positive airway pressure

Treatment groups

134 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Murdoch Childrens Research Institute

Lead sponsor

Western Health, Australia

Collaborator

Royal Women's Hospital, Melbourne, Australia

Collaborator